logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > White Crystalline Solid Tenofovir CAS 147127-20-6

White Crystalline Solid Tenofovir CAS 147127-20-6

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 147127-20-6

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:

CAS 147127-20-6 Tenofovir

,

CAS 147127-20-6

,

White Crystalline Solid Tenofovir

Appearance::
White Crystalline Solid
CAS NO::
147127-20-6
Molecular Formula::
C9H14N5O4P
Molecular Weight::
287.21200
EINECS NO::
604-571-2
MDL NO::
MFCD00943794
Appearance::
White Crystalline Solid
CAS NO::
147127-20-6
Molecular Formula::
C9H14N5O4P
Molecular Weight::
287.21200
EINECS NO::
604-571-2
MDL NO::
MFCD00943794
White Crystalline Solid Tenofovir CAS 147127-20-6

Product Description:

Product Name: Tenofovir CAS NO: 147127-20-6


Synonyms:

(R)-(1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methylphosphonic acid;

Apropovir;

9-Pmpa;


Chemical & Physical Properties:

Appearance: White crystalline solid

Assay :≥99.00%

Density: 1.79 g/cm3

Boiling Point: 616.1℃ at 760 mmHg

Melting Point: 276-280℃

Flash Point: 326.4℃

Water Solubility: 13.4 mg/mL (25℃)


Safety Information:

RTECS: DB8930000

Hazard Class: 8

Safety Statements: S22; S26; S27; S36/37/39

HS Code: 2933990090

WGK Germany: 3

Packing Group: III

RIDADR: UN 3261 8/PG 2

Risk Statement: R34

Hazard Code: C


Microbicides for s-exually transmitted diseases are pharmacologic agents and chemical substances that are capable of killing or destroying certain microorganisms that commonly cause human infection (for example, the human immunodeficiency virus).

Microbicides are a diverse group of chemical compounds that exert their activity by a variety of different mechanisms of action. Multiple compounds are being developed and tested for their microbicidal activity in clinical trials. Microbicides can be formulated in various delivery systems including gels, creams, lotions, aerosol sprays, tablets or films (which must be used near the time of s-exual intercourse) and sponges and vaginal rings (or other devices that release the active ingredient(s) over a longer period). Some of these agents are being developed for vaginal application, and for rectal use by those engaging in anal sex.

Although there are many approaches to preventing s-exually transmitted diseases in general (and HIV in particular), current methods have not been sufficient to halt the spread of these diseases (particularly among women and people in less-developed nations). S-exual abstinence is not a realistic option for women who want to bear children, or who are at risk of s-exual violence. In such situations, the use of microbicides could offer both primary protection (in the absence of condoms) and secondary protection (if a condom breaks or slips off during intercourse). It is hoped that microbicides may be safe and effective in reducing the risk of HIV transmission during s-exual activity with an infected partner.[full citation needed]


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.